EX-32.1 6 exh32p1.txt Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of K-V Pharmaceutical Company, a Delaware corporation (the "Company"), does hereby certify that, to the best of their knowledge: The Quarterly Report on Form 10-Q for the three and six months ended September 30, 2004 (the "Form 10-Q") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: November 9, 2004 /s/ Marc S. Hermelin ---------------- ----------------------------------------- Marc S. Hermelin Vice Chairman and Chief Executive Officer Date: November 9, 2004 /s/ Gerald R. Mitchell ---------------- ----------------------------------------- Gerald R. Mitchell Vice President and Chief Financial Officer A signed original of this written statement required by Section 906 has been provided to K-V Pharmaceutical Company and will be retained by K-V Pharmaceutical Company and furnished to the Securities and Exchange Commission or its staff upon request.